enterprise Growth at RIL will come at a ‘cost’ The two new growth engines—telecom and retail—strive to take India’s largest corporate to a new peak while its traditional businesses continue to be a drag. By Anto T. Joseph
people For Gaja’s Gopal Jain the focus is on entrepreneurship Despite Covid-19, Gaja Capital’s Gopal Jain has his hands full with deals, and the first-of-its-kind award given to business books. He talks to Fortune India about reforms, entrepreneurship, and more. By Arnav Das Sharma
enterprise Hyderabad, the new vaccine capital of India Apart from Covaxin and Sputnik V, companies based in the city are also involved in developing or manufacturing several other Covid-19 vaccines. By Anto T. Joseph
enterprise How Dabur is riding the new normal The pandemic has seen the 136-year-old company reboot by fast-tracking product launches, embracing automation, upping the emphasis on e-commerce, and focussing on its health portfolio. By Arnika Thakur
enterprise EVs poised to take off, but challenges remain The electric vehicle industry believes that the pandemic and the Indian government's policies have given the nascent sector a much needed boost. But more work remains to be done. By Prerna Lidhoo
people Business travel has structurally changed: IndiGo CEO United Airlines, Air Canada, US Airways, and Air Sahara were Ronojoy Dutta’s stamping grounds, before IndiGo. Since then, it hasn’t been clear blue skies for the man. He now sees tailwinds emerging. By Anshul Dhamija
enterprise Building the Metropolis of the future Ameera Shah's Metropolis Healthcare is all set to acquire Hitech Diagnostics Centre. Here's Fortune India's earlier story on how Shah is transforming her fast-growing pathlab company. By Sourav Majumdar
enterprise Bandhan Bank: An ear to the ground Beginning its life as a microfinance company, Bandhan Bank has made its name as a commercial bank to watch out for. It now wants to leapfrog into the future. Will it be able to work its magic again? By Debojyoti Ghosh
covid-19-vaccine-in-india Covid-19 vaccine: The accessibility challenge While the government rolled out the Covid-19 vaccination programme on January 16, questions of accessibility and affordability remain for sections of the population. By Arnav Das Sharma
macro Why ‘One District One Product’ is critical to U.P. The Yogi Adityanath administration is pulling out all stops to showcase the government’s development agenda. By Sourav Majumdar
